Terms: = Leukemia AND CCND1, BCL1, 595, ENSG00000110092, PRAD1, U21B31, D11S287E AND Prognosis
52 results:
1. Decitabine as epigenetic priming with CLAG induce improved outcome of relapsed or refractory acute myeloid leukemia in children.
Zhang N; Li H; Wang D; Wang Z; Zhu JS; Chen K; Jiang H; Shao JB; Cai C
Clin Epigenetics; 2024 May; 16(1):63. PubMed ID: 38725010
[TBL] [Abstract] [Full Text] [Related]
2. GLI1 polymorphisms influence remission rate and prognosis of young de novo acute myeloid leukemia patients treated with cytarabine-based chemotherapy.
Liu Y; Liu Y; Chen P; Chen G; Chen X
Ann Hematol; 2024 Jun; 103(6):1967-1977. PubMed ID: 38676765
[TBL] [Abstract] [Full Text] [Related]
3. Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH): a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis.
Knauft J; Schenk T; Ernst T; Schnetzke U; Hochhaus A; La Rosée P; Birndt S
Leukemia; 2024 Feb; 38(2):235-249. PubMed ID: 38238443
[TBL] [Abstract] [Full Text] [Related]
4. Illuminating (HTLV-1)-induced adult T-cell leukemia/lymphoma transcriptomic signature: A systems virology approach.
Forghani-Ramandi MM; Mostafavi B; Bahavar A; Dehghankar M; Siami Z; Mozhgani SH
Virus Res; 2023 Dec; 338():199237. PubMed ID: 37832654
[TBL] [Abstract] [Full Text] [Related]
5. Emerging entities: high-grade/large B-cell lymphoma with 11q aberration, large B-cell lymphoma with IRF4 rearrangement, and new molecular subgroups in large B-cell lymphomas. A report of the 2022 EA4HP/SH lymphoma workshop.
Quintanilla-Martinez L; Laurent C; Soma L; Ng SB; Climent F; Ondrejka SL; Zamo A; Wotherspoon A; de Leval L; Dirnhofer S; Leoncini L
Virchows Arch; 2023 Sep; 483(3):281-298. PubMed ID: 37555980
[TBL] [Abstract] [Full Text] [Related]
6. ZC3H15 Correlates with a Poor prognosis and Tumor Progression in Melanoma.
Li Q; Hou J; Guo C; Zhang Y; Liu L; Hu H; Shi S; Ji Y; Guo L; Shi Y; Liu Y; Cui H
Biomed Res Int; 2021; 2021():8305299. PubMed ID: 34988227
[TBL] [Abstract] [Full Text] [Related]
7. Targeted RNA-Sequencing Enables Detection of Relevant Translocations and Single Nucleotide Variants and Provides a Method for Classification of Hematological Malignancies-RANKING.
de Lange K; de Boer EN; Bosga A; Alimohamed MZ; Johansson LF; Mulder AB; Vellenga E; van Diemen CC; Deelen P; van den Berg E; Sikkema-Raddatz B
Clin Chem; 2020 Dec; 66(12):1521-1530. PubMed ID: 33257979
[TBL] [Abstract] [Full Text] [Related]
8. Cyclin D1 G870A Polymorphism: Relation to the Risk of ALL Development, prognosis Impact, and Methotrexate Cytotoxicity.
El Menshawy N; El Marghany AB; Sarhan MM; Aladle DA
Asian Pac J Cancer Prev; 2020 Oct; 21(10):2941-2947. PubMed ID: 33112552
[TBL] [Abstract] [Full Text] [Related]
9. MLL-AF9 initiates transformation from fast-proliferating myeloid progenitors.
Chen X; Burkhardt DB; Hartman AA; Hu X; Eastman AE; Sun C; Wang X; Zhong M; Krishnaswamy S; Guo S
Nat Commun; 2019 Dec; 10(1):5767. PubMed ID: 31852898
[TBL] [Abstract] [Full Text] [Related]
10. 98% IGHV gene identity is the optimal cutoff to dichotomize the prognosis of Chinese patients with chronic lymphocytic leukemia.
Shi K; Sun Q; Qiao C; Zhu H; Wang L; Wu J; Wang L; Fu J; Young KH; Fan L; Xia Y; Xu W; Li J
Cancer Med; 2020 Feb; 9(3):999-1007. PubMed ID: 31849198
[TBL] [Abstract] [Full Text] [Related]
11. A six-gene leukemic stem cell score identifies high risk pediatric acute myeloid leukemia.
Elsayed AH; Rafiee R; Cao X; Raimondi S; Downing JR; Ribeiro R; Fan Y; Gruber TA; Baker S; Klco J; Rubnitz JE; Pounds S; Lamba JK
Leukemia; 2020 Mar; 34(3):735-745. PubMed ID: 31645648
[TBL] [Abstract] [Full Text] [Related]
12. Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
López-Guerra M; Xargay-Torrent S; Fuentes P; Roldán J; González-Farré B; Rosich L; Silkenstedt E; García-León MJ; Lee-Vergés E; Giménez N; Giró A; Aymerich M; Villamor N; Delgado J; López-Guillermo A; Puente XS; Campo E; Toribio ML; Colomer D
Oncogene; 2020 Feb; 39(6):1185-1197. PubMed ID: 31616059
[TBL] [Abstract] [Full Text] [Related]
13. CD23 expression in mantle cell lymphoma is associated with CD200 expression, leukemic non-nodal form, and a better prognosis.
Saksena A; Yin CC; Xu J; Li J; Zhou J; Wang SA; Lin P; Tang G; Wang L; Wang M; Miranda RN; Medeiros LJ; Li S
Hum Pathol; 2019 Jul; 89():71-80. PubMed ID: 31054894
[TBL] [Abstract] [Full Text] [Related]
14. [Diagnostic and therapeutic values of interphase fluorescence in situ hybridization in B-cell lymphomas: a clinicopathologic analysis of 604 cases].
Chen M; Yang JL; Zhao S; Liu WP; Li GD; Ye YX; Yan JQ; Zhang WY
Zhonghua Bing Li Xue Za Zhi; 2018 Dec; 47(12):920-925. PubMed ID: 30522172
[No Abstract] [Full Text] [Related]
15. Identification of gene expression models for laryngeal squamous cell carcinoma using co-expression network analysis.
Yang CW; Wang SF; Yang XL; Wang L; Niu L; Liu JX
Medicine (Baltimore); 2018 Feb; 97(7):e9738. PubMed ID: 29443735
[TBL] [Abstract] [Full Text] [Related]
16. Effect of NPM1 type B mutation on the proliferation, invasion and chemosensitivity of THP-1 leukemia cells.
Peng J; Fu B; Fu G; Zhao X; Li X; Chen F
Pharmazie; 2017 Oct; 72(10):608-613. PubMed ID: 29441887
[TBL] [Abstract] [Full Text] [Related]
17. Endogenous Tumor Suppressor microRNA-193b: Therapeutic and Prognostic Value in Acute Myeloid leukemia.
Bhayadia R; Krowiorz K; Haetscher N; Jammal R; Emmrich S; Obulkasim A; Fiedler J; Schwarzer A; Rouhi A; Heuser M; Wingert S; Bothur S; Döhner K; Mätzig T; Ng M; Reinhardt D; Döhner H; Zwaan CM; van den Heuvel Eibrink M; Heckl D; Fornerod M; Thum T; Humphries RK; Rieger MA; Kuchenbauer F; Klusmann JH
J Clin Oncol; 2018 Apr; 36(10):1007-1016. PubMed ID: 29432078
[TBL] [Abstract] [Full Text] [Related]
18. Prediction of outcome in newly diagnosed myeloma: a meta-analysis of the molecular profiles of 1905 trial patients.
Shah V; Sherborne AL; Walker BA; Johnson DC; Boyle EM; Ellis S; Begum DB; Proszek PZ; Jones JR; Pawlyn C; Savola S; Jenner MW; Drayson MT; Owen RG; Houlston RS; Cairns DA; Gregory WM; Cook G; Davies FE; Jackson GH; Morgan GJ; Kaiser MF
Leukemia; 2018 Jan; 32(1):102-110. PubMed ID: 28584253
[TBL] [Abstract] [Full Text] [Related]
19. Chronic myelogenous leukemia with acquired t(11;14)(q13;q32) ccnd1-IGH: A case report and literature review.
Manda-Mapalo MT; Khalili P; Quintana D; Rabinowitz I; Zhang QY
Cancer Genet; 2016 Oct; 209(10):481-485. PubMed ID: 27810077
[TBL] [Abstract] [Full Text] [Related]
20. Differential PAX5 levels promote malignant B-cell infiltration, progression and drug resistance, and predict a poor prognosis in MCL patients independent of ccnd1.
Teo AE; Chen Z; Miranda RN; McDonnell T; Medeiros LJ; McCarty N
Leukemia; 2016 Mar; 30(3):580-93. PubMed ID: 26073757
[TBL] [Abstract] [Full Text] [Related]
[Next]